World / Science & Health Oct 9, 2019
GSK recalls popular heartburn drug Zantac globally amid cancer scare
GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a "precaution," days after the U.S. Food and Drug Administration found "unacceptable" levels of probable cancer-causing impurity in the drug. Zantac, also sold generically as ranitidine, is the latest ...
